ストックスクリーナーアプリを入手
6.67
6.55%
0.41
前日終値:
$6.26
開ける：
$6.25
24時間の取引高:
1.14M
Relative Volume:
2.29
時価総額：
$398.26M
収益：
-
当期純損益:
$-44.80M
株価収益率:
-8.8933
EPS:
-0.75
ネットキャッシュフロー:
$-30.67M
1週間 パフォーマンス:
+1.37%
1か月 パフォーマンス:
+5.21%
6か月 パフォーマンス:
+21.27%
1年 パフォーマンス:
+103.98%
1日の値動き範囲:
$6.15
$6.73
1週間の範囲:
$6.15
$6.8094
52週間の値動き範囲:
$3.10
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
名前
Aldeyra Therapeutics Inc
セクター
電話
781-761-4904
住所
131 HARTWELL AVENUE, LEXINGTON, MA
ALDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
6.67 | 398.26M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-03 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-04-02 | 再開されました | H.C. Wainwright | Buy |
| 2022-04-27 | 再開されました | H.C. Wainwright | Buy |
| 2021-02-08 | 開始されました | H.C. Wainwright | Buy |
| 2020-12-16 | 開始されました | Berenberg | Buy |
| 2020-10-30 | 開始されました | Jefferies | Buy |
| 2020-10-16 | 開始されました | BTIG Research | Buy |
| 2020-09-22 | 開始されました | Alliance Global Partners | Buy |
| 2020-05-12 | 開始されました | Oppenheimer | Outperform |
| 2018-12-04 | 開始されました | Citigroup | Buy |
| 2018-09-26 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-09-13 | 開始されました | Janney | Buy |
| 2018-01-26 | 開始されました | Seaport Global Securities | Buy |
| 2016-09-26 | 開始されました | H.C. Wainwright | Buy |
| 2016-07-01 | 開始されました | Stifel | Buy |
| 2015-07-01 | 開始されました | Canaccord Genuity | Buy |
| 2015-03-25 | 開始されました | Chardan Capital Markets | Buy |
| 2015-03-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2014-11-18 | 開始されました | H.C. Wainwright | Buy |
| 2014-06-19 | 開始されました | Aegis Capital | Buy |
すべてを表示
Aldeyra Therapeutics Inc (ALDX) 最新ニュース
SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Raymond James Financial Inc. Invests $3.63 Million in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
Trend Tracker for (ALDX) - Stock Traders Daily
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Passes Above 50-Day Moving Average – Here’s Why - Defense World
SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALDX - Business Wire
BTIG maintains Aldeyra stock Buy rating, $11 target By Investing.com - Investing.com Canada
Aldeyra Therapeutics Beats Investor Suit Over Eye Drug Misses - Bloomberg Law
(ALDX) On The My Stocks Page - Stock Traders Daily
Biotech Wins Dismissal Of Investor Fraud Claims - Law360
ALDX stock touches 52-week high at $6.93 amid robust gains - Investing.com Australia
ALDX stock touches 52-week high at $6.93 amid robust gains By Investing.com - Investing.com South Africa
Tech Stocks Defying Market Volatility: Meet the Pioneers of Tomorrow’s Economy - DSA
High Growth Tech Stocks To Watch In The US March 2025 - Simply Wall St
Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference - Business Wire
Aldeyra Therapeutics CEO Scheduled for Fireside Chat at Major Healthcare Conference - StockTitan
Aldeyra Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Q1 Earnings Estimate for ALDX Issued By HC Wainwright - Defense World
How to Take Advantage of moves in (ALDX) - Stock Traders Daily
Aldeyra Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aldeyra Therapeutics Is Severely Undervalued Before PDUFA - Seeking Alpha
Chronic Cough Market Expected to rise, 2034 | Merck & Co, Kyorin Pharmaceuticals, NeRRe Therapeutics, Bellus Health, GSK, Axalbion, Aldeyra Therapeutics, Genentech, Inc., expected to drive market - Barchart
Chronic Cough Market Expected to rise, 2034 | Merck & Co, Kyorin - openPR
Aldeyra Therapeutics (NASDAQ:ALDX) Receives Buy Rating from HC Wainwright - Defense World
Aldeyra Therapeutics Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Aldeyra Therapeutics Inc [ALDX] Insider Activity: An Update for Investors - Knox Daily
Clearside Biomedical Inc. Revolutionizes Panuveitis Treatment With Innovative Xipere Product: Key Trend in ... - WhaTech
Aldeyra Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Aldeyra Therapeutics, Inc. SEC 10-K Report - TradingView
Best Stocks Under $10 • Charts Updated Daily - Benzinga
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Aldeyra Therapeutics, Inc. (ALDX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Aldeyra Therapeutics (ALDX) Expected to Announce Quarterly Earnings on Thursday - Defense World
(ALDX) Trading Report - Stock Traders Daily
AlphaCentric Advisors LLC Acquires New Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat
In-Depth Analysis Of The Chronic Plaque Psoriasis Market: Key Drivers, Trends, Growth Opportunities And - EIN News
Global Microtome Market to Exhibit Growth at a CAGR of ~6% by 2032 | DelveInsight - GlobeNewswire
Retinitis Pigmentosa Drugs Market 2034: EMA, PDMA, FDA - openPR
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge - GlobeNewswire
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation ... - The Bakersfield Californian
ALDX stock touches 52-week high at $6.6 amid robust annual gains - MSN
Why Aldeyra Therapeutics Inc (NASDAQ: ALDX) Is A Great Stock Pick For Momentum Investors - Stocks Register
Dry Eye Disease Clinical Trial Pipeline | 45+ Companies Pioneering the Future of Treatment - EIN News
(ALDX) Proactive Strategies - Stock Traders Daily
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stake Raised by SG Americas Securities LLC - Defense World
Dry Eye Disease Market Poised for Major Advancements by 2034, Reveals DelveInsight - WICZ
Aldeyra Therapeutics Inc (ALDX) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Aldeyra Therapeutics (NASDAQ:ALDX) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Retinitis Pigmentosa Treatment Market Industry Growth - openPR
Exclusive Fireside Chat: Aldeyra CEO Reveals Company Strategy at Major Healthcare Conference - StockTitan
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Significant Growth in Short Interest - MarketBeat
How the (ALDX) price action is used to our Advantage - Stock Traders Daily
Aldeyra Therapeutics Inc (ALDX) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):